ImmunityBio's total assets for Q were $444.32M, an increase of 10.89% from the previous quarter. IBRX total liabilities were $1.14B for the fiscal quarter, a 4.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.